(Press-News.org) Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet in Sweden shows that some immune cells with high inflammatory potential are not completely eradicated after treatment.
Biological drugs (biologics) have become an important tool in the treatment of severe asthma.
“They help most patients to keep their symptoms under control, but exactly how these drugs affect the immune system has so far remained unknown,” says Valentyna Yasinska, consultant in pulmonary medicine at Karolinska University Hospital and doctoral student at Karolinska Institutet’s Department of Medicine in Huddinge.
In a new study published in the scientific journal Allergy, researchers at Karolinska Institutet have explored what happens to the immune cells of patients being treated with biologics. By analysing blood samples from 40 patients before and during treatment, they found that instead of disappearing during treatment, certain types of immune cell – which play a key part in asthma inflammation – actually increased.
“This suggests that biologics might not attack the root of the problem, no matter how much they help asthma patients during treatment,” says Jenny Mjösberg, professor of tissue immunology at Karolinska Institutet’s Department of Medicine in Huddinge. “Continued treatment might be necessary to keep the disease under control.”
The study is based on data from patients with severe asthma sourced from the BIOCROSS study. The researchers used advanced methods such as flow cytometry and single-cell sequencing to determine the properties and function of the immune cells.
“We were surprised to find that blood levels of inflammatory cells increased rather than decreased,” says Lorenz Wirth, doctoral student at the same department at Karolinska Institutet. “This could explain why inflammation of the airways often returns when the treatment is tapered or discontinued. It is important that we understand the long-term immunological effects of these drugs.”
Little is still known about the long-term effects of biologics like mepolizumab and dupilumab since they are relatively new, having been prescribed to asthmatics for less than ten years.
The next stage of the study will be to analyse samples from patients with a long treatment history and to study lung tissue to see how the immune cells are affected in the airways.
The study was financed by grants from the EU (Horizon 2020), the Swedish Heart-Lung Foundation, the Centre for Innovative Medicine, the Swedish state, the Torsten Söderberg Foundation, Karolinska Institutet and the ChAMP Consortium.
Any conflicts of interest are reported in the published paper.
Publication: “High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma”, Lorenz Wirth, Whitney Weigel, Christopher T Stamper, Johan Kolmert, Sabrina de Souza Ferreira, Quirin Hammer, Maria Sparreman Mikus, Jakob Theorell, Lars I Andersson, Ann-Sofie Lantz, Eva Wallén Nielsen, Anne Petrén, Craig E Wheelock, Apostolos Bossios, Nikolaos Lazarinis, Andrei Malinovschi, Christer Janson, Barbro Dahlén, Thomas Hochdörfer, Christopher Andrew Tibbitt, Sven-Erik Dahlén, Valentyna Yasinska, Jenny Mjösberg, Allergy, online 26 June 2025, doi: 10.1111/all.16633.
END
Inflammatory cells remain in the blood after treatment of severe asthma
2025-06-26
ELSE PRESS RELEASES FROM THIS DATE:
New insights into seasonal shifts in sleep
2025-06-26
A new international study drawing on 73 million nights of data reveals that our sleep patterns are seriously shaped by the day of the week, the season, and where we live.
Working with sleep data from more than 116,000 adults across the globe, Flinders University sleep experts used insights from an FDA-cleared under-mattress device to track sleep duration and timing over 3.5 years.
Lead author, Dr Hannah Scott from FHMRI Sleep Health says the findings give a detailed look at how geography, seasons, and our day-to-day schedules quietly disrupt the way we sleep.
“Sleep patterns aren’t just about habits – they’re deeply connected to the environment around ...
Estimating microbial biomass from air-dried soils: A safer, scalable approach
2025-06-26
Niigata, Japan— In a remarkable advancement for soil science, researchers from Japan have developed a novel method for estimating microbial biomass using water-extractable organic matter (WEOM) from air-dried soils. This innovative approach not only simplifies the estimation process but also eliminates the need for toxic solvents typically used in traditional methods, such as chloroform fumigation extraction.
A research was conducted by a dedicated team from Niigata University, Kyushu University, Japan Atomic Energy Agency, and Anhui Academy of Agricultural Sciences researchers. The study analyzed 50 soil samples from ten diverse profiles across various regions in Japan, including six ...
AI in healthcare needs patient-centred regulation to avoid discrimination – new commentary
2025-06-26
New commentary published in the Journal of the Royal Society of Medicine warns that current risk-based regulatory approaches to Artificial Intelligence (AI) in healthcare fall short in protecting patients, potentially leading to over- and undertreatment as well as discrimination against patient groups.
The authors found that while AI and machine learning systems can enhance clinical accuracy, concerns remain over their inherent inaccuracy, opacity, and potential for bias which are not adequately addressed by the current regulatory ...
A good soak in a hot tub might beat a sauna for health benefits
2025-06-25
Hot tubs and saunas can both soothe aching muscles and provide welcome warmth, but hot tubs might offer greater health benefits.
That’s the takeaway from a new study done by researchers in the Bowerman Sports Science Center at the University of Oregon, which compared the physiological effects of soaking in a hot tub to sitting in a traditional dry heat sauna or a more modern far-infrared sauna.
By raising core body temperatures, soaking in hot water can help lower blood pressure, stimulate the immune system and, over time, improve the body’s ...
Surgery plus speech therapy linked to improved language after stroke
2025-06-25
Combining neck surgery with intensive speech therapy is associated with greater improvements in a person's ability to communicate after a stroke than intensive speech therapy alone, finds a clinical trial published by The BMJ today.
The results show improvements immediately after surgery without any long-term severe adverse events or lasting discomfort, as well as reported improvements in quality of life and post-stoke depression over six months.
Stroke is the most common cause of aphasia (problems with communication, including speaking, understanding others, reading and writing). More than 60% of patients are ...
GP performance pay fails to drive lasting changes in quality of care
2025-06-25
Introducing performance related pay for UK general practices initially improved quality of care, but did not seem to provide lasting improvements beyond that expected by previous trends, finds a study published by The BMJ today.
And initial gains in quality seemed to reverse when financial incentives were withdrawn, say the researchers.
The UK Quality and Outcomes Framework (QOF) pay-for-performance programme was introduced across the NHS in 2004 to reward general practices for providing high quality care across a range of disease indicators ...
Focusing on weight loss alone for obesity may do more harm than good
2025-06-25
Focusing solely on achieving weight loss for people with a high body mass index (BMI) may do more harm than good, argue experts in The BMJ today.
Dr Juan Franco and colleagues say, on average, people with high weight will not be able to sustain a clinically relevant weight loss with lifestyle interventions, while the potential harms of weight loss interventions, including the reinforcement of weight stigma, are still unclear.
They stress that a healthy lifestyle has important benefits, but that weight alone might not give an adequate picture of someone’s health, and say doctors should provide high quality, evidence based care reflecting individual preferences ...
In sub-Saharan Africa, 1 in 6 cancer medications found to be defective
2025-06-25
Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.
For the study published in The Lancet Global Health, researchers collected different cancer medications from Cameroon, Ethiopia, Kenya and Malawi and evaluated whether each drug met regulatory standards. Researchers considered a variety of factors, including appearance, packaging, labeling and, most importantly, the assay value.
The assay value is the quantity of active pharmaceutical ingredient (API) found in each drug. To meet safety standards, most products should be within a ...
Newborns require better care to improve survival and long-term health
2025-06-25
More effective platforms for drug and medical device development and better cross sector engagement are urgently required to prevent the ‘unacceptably high’ newborn death rate, according to a global report.
The Lancet Child & Adolescent Health Commission on the future of neonatology report found this field of medicine faced significant challenges across leadership, collaboration, regulation and funding, which were hindering better health outcomes for newborns.
The Lancet Commission was created to consider these challenges and design a roadmap to accelerate research and development ...
EMBARGOED: New study shows almost half of hospital patients in Malawi and Tanzania have multiple health conditions
2025-06-25
The Multilink Consortium, a NIHR-funded partnership between the Liverpool School of Tropical Medicine, the Malawi-Liverpool-Wellcome Programme, Muhimbili University of Health and Allied Sciences and Kilimanjaro Christian Medical University College, has published the first-of-its-kind research in sub-Saharan Africa to examine the scale and impact of ‘multimorbidity’ in patients admitted acutely to hospital. Multimorbidity refers to the presence of two or more chronic diseases.
Researchers discovered that of 1007 ...